Biomimetic Hierarchical Construction of Anti‐Tumor Polyoxopalladates for Cancer Therapy

Y Yue Zhao Z Zheran Liu (School of Science Constructor University Campus Ring 1 28759 Bremen Germany) Z Zijian Qin (School of Science Constructor University Campus Ring 1 28759 Bremen Germany) Q Qinlong Wen (Department of Biotherapy, Cancer Center) J Jing Du X Xiang‐Yu Ren (Department of Biotherapy Cancer Center West China Hospital Sichuan University Chengdu 610041 P. R. China) C Chao‐Qin Chen (College of Chemistry and Chemical Engineering, Advanced Catalytic Engineering Research Center of the Ministry of Education Hunan University Changsha 410082 P.R. China) X Xingchen Peng (Department of Biotherapy, Cancer Center) U Ulrich Kortz (School of Science Constructor University Campus Ring 1 28759 Bremen Germany) P Peng Yang

Abstract

AbstractInspired by the construction scheme of biomacromolecules, a hierarchical assembly based on the lacunary polyoxopalladate (POP) of [SrPd12O6(OH)3(PhAsO3)6(OAc)3]4− (SrPd12) has been achieved. As a structurally programmable molecular building block, SrPd12 is used to evolve from monomer via dimer to supramolecular aggregates in a controlled manner. In such process, the open‐shell‐type monomers are covalently integrated into bowl‐ or cage‐like dimers via a direct or indirect splicing strategy. Upon that, hydrogen bond and hydrophobic effects are further hired to fabricate supramolecular aggregates of varied host–guest archetypes, thereby completing a hierarchical construction. In consideration of the combined advantages of noble metals and polyoxometalates in cancer treatment, both in vitro and in vivo anti‐tumor assays of these SrPd12‐derived POPs were studied in detail. A structure‐dependent anti‐tumor activitywas observed, originating from an imbalance of damage and repair of DNA as anti‐tumor mechanism.

Article Details

Volume / Issue Vol. 64, Issue 23
Published June 02, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (10)

Y

Yue Zhao

Z

Zheran Liu

School of Science Constructor University Campus Ring 1 28759 Bremen Germany

Z

Zijian Qin

School of Science Constructor University Campus Ring 1 28759 Bremen Germany

Q

Qinlong Wen

Department of Biotherapy, Cancer Center

J

Jing Du

X

Xiang‐Yu Ren

Department of Biotherapy Cancer Center West China Hospital Sichuan University Chengdu 610041 P. R. China

C

Chao‐Qin Chen

College of Chemistry and Chemical Engineering, Advanced Catalytic Engineering Research Center of the Ministry of Education Hunan University Changsha 410082 P.R. China

X

Xingchen Peng

Department of Biotherapy, Cancer Center

U

Ulrich Kortz

School of Science Constructor University Campus Ring 1 28759 Bremen Germany

P

Peng Yang